Qualification and Examination Information

News Highlights

The news regarding “Qualification and Examination Information,” announced on May 1, 2026, emphasizes the importance of third-party succession as an alternative to clinic closure or business dissolution in addressing the issue of successors in medical institutions. It specifically recommends that directors and presidents begin preparing for business succession with a long-term perspective of 5 to 10 years, starting around the age of 60, and advocates for the utilization of specialized advisors focused on the medical industry.

M&A Medical Editorial Department’s Perspective

This news offers concrete action guidelines for the pressing issue of successor shortages in medical institutions, going beyond generic advice like “early consideration” or “utilizing experts.” In particular, the 5-10 year preparation period starting around age 60 is a realistic timeline for achieving smooth third-party succession, as is evident in the field of M&A brokerage. For instance, there is an increasing number of cases where clinics facing a lack of successors transition to a new management structure through business transfer schemes, while simultaneously maintaining regional medical care and securing employee employment. This option of “third-party succession” not only prevents the creation of healthcare gaps due to clinic closures or business dissolutions but also represents an extremely valuable choice from the perspectives of securing founder’s profits and inheriting long-cultivated medical expertise.

Points Raised by This News

• Preparing for business succession over a 5-10 year period starting around age 60 aligns with the realities of the M&A brokerage field.
• Third-party succession as an alternative to clinic closure or business dissolution leads to the dual goals of maintaining regional medical care and securing employment.
• Business succession in medical institutions extends beyond a mere transfer of management rights, also encompassing the aspect of knowledge and expertise inheritance.
• Specialized advisors support the construction of schemes that consider the unique regulations and customs of the medical industry.

Practical Questions Arising from This News

• Specifically, what kind of third-party succession schemes (e.g., stock transfer, business transfer) are suitable for our clinic?
• In cases of successor absence, which is more realistic: succession by employees (MBO) or sale to an external party?
• When consulting with a specialized advisor for medical M&A, what kind of information and documents should be prepared?

If You Feel “Should I Consult?”

If your clinic’s director or president is approaching 60 and feels anxious about the lack of a successor, or is vaguely considering future business succession, this news serves as a timely prompt to consider concrete actions. Before facing the option of clinic closure or business dissolution, we recommend consulting with a specialist in medical M&A to explore the possibilities of third-party succession, aiming to balance contributions to regional healthcare with your own asset building. Early consultation is key to achieving succession under more favorable terms.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution, operating on a full success fee basis. Consultations are handled with strict confidentiality. Free consultation here